Ambassador Deborah Birx, MD, told Infection Control Today® exclusively, “Every mistake that we made with COVID-19 in January and February of 2020, repeated in real time with monkeypox.”
How infectious disease is handled in the United States is different than it is in the United Kingdom. With this fact in mind, did the United States learn from the COVID-19 pandemic and is the US prepared for new diseases to arrive compared to how the UK handled it? What about a new disease on US shores, like monkeypox? Is the US ready? According to an infectious disease expert, Ambassador Deborah Birx, MD, a world-renowned medical expert and leader, sat down with Infection Control Today® (ICT®), and said that the US has the tools, but we are not prepared.
In this second of 4 installments of the ICT®’s exclusive interview, Birx discusses what she sees as the mistakes the United States made with the beginning of monkeypox. Other topics covered in the interview her upcoming presentation titled, “COVID-19 USA - Lessons and new tools to improve workplace safety “at the Frontline Worker Safety in the Age of COVID-19: A Global Perspective” a Health Watch USAs Webinar on September 14, 2022, medical infrastructure, and monkeypox, Langya virus, among other topics.
The first installment of the interview is here.
“I don't know whether we [the United States] think we're exceptional when it comes to infectious disease, [but] we are not,” Birx told ICT®. “We've had higher fatalities, about 60% more fatalities in this country than the United Kingdom over the last 18 months because we didn't use the tools that we had for COVID-19. “The UK expanded testing and expanded knowledge and got tests, even into small communities, educating the public, and saying, ‘If you test before you see your elderly grandparents or if you are sick, you'll prevent most of the spread of this virus.’ [But] we didn't do that; the UK did. And their fatalities through Delta and Omicron [variants] are 60% less. So there are tools out there, and there is knowledge, and we know exactly what's happening. But we're not using any of those things to combat the diseases that we're seeing.”
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.